Federal Judge Upholds FDA Approval of Pfizer's COVID-19 Treatment, Etoricoxabane, for High-Risk Patients

Summary

A federal judge has ruled in favor of Pfizer, upholding the FDA's approval of its COVID-19 treatment, Etoricoxabane, for patients at high risk of severe illness from the virus, as recommended by the FDA's advisory committee